AngioDynamics
Company Snapshot
Founded: 1988
Entity Type: Public
Employees: 675
Region: U.S.
Revenue: $292.5 Millions
Revenue Year: 2024
Headquarter: New York, U.S.
Key Geographics: U.S., International
Corporate Address: 14 Plaza Drive Latham New York 12110 U.S. Tel. +1-(800)-772-6446 www.angiodynamics.com
Company Overview
AngioDynamics Inc. is a U.S.-based medical technology company specializing in vascular access, peripheral vascular intervention, oncology, and surgical technologies. Within the IV therapy and vein access market, it offers a broad portfolio of vascular access products, including central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midline catheters, dialysis catheters, implantable ports, and vascular access accessories. AngioDynamics focuses on product innovation and minimally invasive technologies to enhance patient safety, improve vascular access outcomes, and reduce catheter-related complications across hospitals and outpatient care settings.
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
AngioDynamics In News
Company's Business Segments
- Med Tech : This segment provides Auryon Atherectomy System, AngioVac, AlphaVac, Thrombolytic Catheters, and NanoKnife.
- Med Device : This segment provides peripheral products such as Angiographical Catheters and guidewires, Drainage Products, Micropuncture Kits, Port Technologies, the VenaCure EVLT laser system, and and the Solero Microwave Tissue Ablation (MTA) System.
Applications/End User Industries
- Healthcare
- Medical Devices
- Medical Technology